ストックスクリーナーアプリを入手
1.48
4.96%
0.07
アフターアワーズ：
1.47
-0.01
-0.68%
前日終値:
$1.41
開ける：
$1.41
24時間の取引高:
100.44K
Relative Volume:
0.83
時価総額：
$6.49M
収益：
$3.19M
当期純損益:
$-10.42M
株価収益率:
-0.0417
EPS:
-35.4757
ネットキャッシュフロー:
$-10.65M
1週間 パフォーマンス:
+3.50%
1か月 パフォーマンス:
-10.84%
6か月 パフォーマンス:
-19.57%
1年 パフォーマンス:
-60.71%
1日の値動き範囲:
$1.41
$1.4856
1週間の範囲:
$1.3313
$1.4856
52週間の値動き範囲:
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
INBS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.48 | 6.49M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
113.83 | 197.43B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
361.52 | 137.82B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.69 | 133.66B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.95 | 103.80B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.91 | 43.59B | 6.60B | 4.16B | 490.10M | 6.93 |
Intelligent Bio Solutions Inc (INBS) 最新ニュース
Intelligent Bio Solutions (NASDAQ:INBS) Stock Quotes, Forecast and News Summary - Benzinga
How maker of drug tests Intelligent Bio Solutions builds its business on people’s tendency to lie - Kursiv Media
Intelligent Bio Solutions Submits FDA Premarket Notification - TipRanks
Intelligent Bio Gains On Applying For Fingerprinting Review - Barchart
Intelligent Bio Gains on Applying for Fingerprinting Review - Baystreet.ca
INBS seeks FDA clearance for fingerprint drug test - Investing.com
Intelligent Bio Solutions Inc. Submits FDA 510(k) Application for Intelligent Fingerprinting Drug Screening System - Nasdaq
Intelligent Bio Solutions Announces 510(k) Submission to US - GlobeNewswire
Intelligent Bio Solutions Files FDA Application for 94% Accurate 10-Minute Drug Screening Breakthrough - StockTitan
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - Marketscreener.com
Intelligent Bio Solutions CEO to Discuss FDA Path & Clinical Results in Upcoming Fireside Chat - StockTitan
Intelligent Bio Solutions Releases Business Operations Presentation - TipRanks
Intelligent Bio Solutions completes fingerprint drug screening system study - MSN
Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks
Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times
Intelligent Bio Solutions Hits 94% Accuracy in Drug Screening Breakthrough Study - StockTitan
Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan
Intelligent Bio Solutions raises $250k via stock sales - Investing.com
Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com Canada
INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Inventory Turnover : 0.69 (As of Sep. 2024) - GuruFocus.com
Intelligent Bio Solutions Announces Study Results and Stock Sale - TipRanks
INBS (Intelligent Bio Solutions) Price-to-Free-Cash-Flow : N/A (As of Nov. 20, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Intelligent Bio : INBS PK Study Results Video - Marketscreener.com
INBS (Intelligent Bio Solutions) EBITDA per Share : $-30.36 (TTM As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Total Assets : $11.73 Mil (As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) PensionAndRetirementBenefi - GuruFocus.com
INBS (Intelligent Bio Solutions) Price-to-Operating-Cash-Fl - GuruFocus.com
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - MSN
Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com
Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance
INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia
Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
INBS advances in drug detection with fingerprint technology - Investing.com
Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com
Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. (INBS) Quarterly 10-Q Report - Quartzy
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - The Manila Times
ConnectM to Participate in the 13th Annual Roth Technology Conference - The Manila Times
Intelligent Bio Solutions Revenue Surges 20% QoQ, FDA Study Milestone Achieved | INBS Stock News - StockTitan
Intelligent Bio Solutions Inc (INBS) 財務データ
収益
当期純利益
現金流量
EPS
0.82%
大文字化:
|
ボリューム (24 時間):